Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology and auto-immune diseases.
Lead Product(s): mRNA-based Therapy
Therapeutic Area: Technology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Large molecule
Partner/Sponsor/Collaborator: Moderna Therapeutics
Deal Size: $85.0 million Upfront Cash: Undisclosed
Deal Type: Acquisition January 04, 2023